Allergy, Asthma & Clinical Immunology (Nov 2011)

Mometasone furoate/formoterol combination therapy increases frequency of days/nights free of short-acting β<sub>2</sub>-agonist use

  • Nayak AS,
  • Nathan RA,
  • Meltzer EO,
  • Weinstein SF,
  • Nolte H

DOI
https://doi.org/10.1186/1710-1492-7-S2-A15
Journal volume & issue
Vol. 7, no. Suppl 2
p. A15

Abstract

Read online

No abstracts available.